Cargando…

Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism

In recent years, metal organic frameworks (MOFs) have attracted increasing attention in cancer therapy, because they can enhance the anticancer efficacy of photodynamic therapy (PDT), photothermal therapy (PTT), photoacoustic imaging, and drug delivery. Owing to stable chemical adjustability, MOFs c...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yingqi, Wu, Wei, Li, Muzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549350/
https://www.ncbi.nlm.nih.gov/pubmed/36225574
http://dx.doi.org/10.3389/fphar.2022.1025780
_version_ 1784805649637441536
author Feng, Yingqi
Wu, Wei
Li, Muzi
author_facet Feng, Yingqi
Wu, Wei
Li, Muzi
author_sort Feng, Yingqi
collection PubMed
description In recent years, metal organic frameworks (MOFs) have attracted increasing attention in cancer therapy, because they can enhance the anticancer efficacy of photodynamic therapy (PDT), photothermal therapy (PTT), photoacoustic imaging, and drug delivery. Owing to stable chemical adjustability, MOFs can be used as carriers to provide excellent loading sites and protection for small-molecule drugs. In addition, MOFs can be used to combine with a variety of therapeutic drugs, including chemotherapeutics drugs, photosensitizers, and radiosensitizers, to efficiently deliver drugs to tumor tissue and achieve desired treatment. There is hardly any review regarding the application of MOFs in hepatocellular carcinoma. In this review, the design, structure, and potential applications of MOFs as nanoparticulate systems in the treatment of hepatocellular carcinoma are presented. Systematic Review Registration: website, identifier registration number
format Online
Article
Text
id pubmed-9549350
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95493502022-10-11 Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism Feng, Yingqi Wu, Wei Li, Muzi Front Pharmacol Pharmacology In recent years, metal organic frameworks (MOFs) have attracted increasing attention in cancer therapy, because they can enhance the anticancer efficacy of photodynamic therapy (PDT), photothermal therapy (PTT), photoacoustic imaging, and drug delivery. Owing to stable chemical adjustability, MOFs can be used as carriers to provide excellent loading sites and protection for small-molecule drugs. In addition, MOFs can be used to combine with a variety of therapeutic drugs, including chemotherapeutics drugs, photosensitizers, and radiosensitizers, to efficiently deliver drugs to tumor tissue and achieve desired treatment. There is hardly any review regarding the application of MOFs in hepatocellular carcinoma. In this review, the design, structure, and potential applications of MOFs as nanoparticulate systems in the treatment of hepatocellular carcinoma are presented. Systematic Review Registration: website, identifier registration number Frontiers Media S.A. 2022-09-26 /pmc/articles/PMC9549350/ /pubmed/36225574 http://dx.doi.org/10.3389/fphar.2022.1025780 Text en Copyright © 2022 Feng, Wu and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Feng, Yingqi
Wu, Wei
Li, Muzi
Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
title Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
title_full Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
title_fullStr Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
title_full_unstemmed Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
title_short Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
title_sort metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549350/
https://www.ncbi.nlm.nih.gov/pubmed/36225574
http://dx.doi.org/10.3389/fphar.2022.1025780
work_keys_str_mv AT fengyingqi metalorganicframeworksforhepatocellularcarcinomatherapyandmechanism
AT wuwei metalorganicframeworksforhepatocellularcarcinomatherapyandmechanism
AT limuzi metalorganicframeworksforhepatocellularcarcinomatherapyandmechanism